Carbon monoxide ( DrugBank: Carbon, Carbon monoxide )

3 diseases

ID	Disease name (Link within this page)	Number of trials
85	Idiopathic interstitial pneumonia	1
86	Pulmonary arterial hypertension	1
298	Hereditary pancreatitis	1

85. Idiopathic interstitial pneumonia

Clinical trials : 598 / Drugs : 435 - (DrugBank : 116) / Drug target genes : 100 - Drug target pathways : 210

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01214187 (ClinicalTrials.gov)	July 2011	30/9/2010	Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis	Phase II Study of Inhaled CO for the Treatment of Idiopathic Pulmonary Fibrosis	Idiopathic Pulmonary Fibrosis	Drug: inhaled carbon monoxide;Other: Oxygen	Brigham and Women's Hospital	National Heart, Lung, and Blood Institute (NHLBI);University of California, San Francisco;University of Chicago;University of Illinois at Chicago;University of Michigan;Columbia University;Tulane University;University of Washington	Completed	18 Years	85 Years	All	58	Phase 2	United States

Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01523548 (ClinicalTrials.gov)	July 2012	27/1/2012	Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension	Carbon Monoxide Therapy for Severe Pulmonary Arterial Hypertension	Hypertension, Pulmonary	Drug: Carbon Monoxide	University of Illinois at Chicago	National Institutes of Health (NIH);National Heart, Lung, and Blood Institute (NHLBI)	Withdrawn	18 Years	N/A	All	0	Phase 1/Phase 2	United States

Clinical trials : 98 / Drugs : 180 - (DrugBank : 57) / Drug target genes : 53 - Drug target pathways : 142

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02567240 (ClinicalTrials.gov)	January 2015	1/10/2015	Carbon Monoxide-Saturated Medium for Islet Isolation	A Novel Approach to Harvest Islets for Autologous Islet Transplantation	Chronic Pancreatitis	Other: Carbon monoxide-bubbled mediums	Medical University of South Carolina	NULL	Completed	18 Years	69 Years	All	16	Phase 1/Phase 2	United States